PHAXIAM Therapeutics S.A.
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$227,000 over the previous period. Total operating expenses were $27,147,000.

Profit Margin

PHAXIAM Therapeutics S.A. (NASDAQ:PHXM): Profit margin
2013 1.80M -8.14M -451.92%
2014 4.36M -8.86M -202.8%
2015 10.77M -15.01M -139.32%
2016 19.71M -21.91M -111.13%
2017 0 -33.53M
2018 0 -38.22M
2019 0 -62.65M
2020 0 -73.3M
2021 0 -53.79M
2022 0 -227K

PHXM Income Statement (2013 – 2022)

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Revenue
Revenue
00000019.71M10.77M4.36M1.80M
Cost of revenue
2.90M5.37M57.58M52.19M33.46M25.46M19.71M10.77M4.36M2.82M
Gross profit
-2.90M-5.37M-57.58M-52.19M-33.46M-25.46M000-1.02M
Operating exp.
Research and development
19.90M45.1M57.58M52.19M33.46M25.46M19.71M10.77M2.24M2.50M
Selling and marketing
0000000000
Total operating expenses
27.14M56.51M68.83M64.07M43.62M30.89M22.39M15.58M4.57M4.25M
Operating income
-2.79M-56.51M-68.83M-64.07M-43.62M-30.88M-22.39M-15.58M-8.94M-7.08M
Other income (expenses), net
24.35M1.17M-747K1.41M5.39M-2.64M488K-1.65M-1.45M19.68K
Income before tax
293K-53.79M-73.29M-62.66M-38.22M-33.53M-21.90M-15.01M-8.88M-8.18M
Income tax expense
521K2K3K-1K2K-3K10K-3K-20.15K-40.01K
Net income
-227K-53.79M-73.3M-62.65M-38.22M-33.53M-21.91M-15.01M-8.86M-8.14M
Earnings per share
Basic EPS
-0.00-2.27-3.99-3.49-2.13-1.87-2.74-2.16-1.51-17.4
Diluted EPS
-0.00-2.27-3.99-3.49-2.13-1.87-2.74-2.16-1.51-17.4